申请人:SCHNEIDER Siegfried
公开号:US20120028952A1
公开(公告)日:2012-02-02
The present invention encompasses compounds of general formula (1)
wherein
R
1
to R
3
are defined as in claim
1
, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned properties.
本发明涵盖了一般式(1)中定义的化合物,其中R1至R3如权利要求1中所定义,适用于治疗以细胞过度或异常增殖为特征的疾病,并用于制备具有上述特性的药物。